Shiga toxin/verotoxin-producing Escherichia coli in humans, food and animals in the EU/EEA, with special reference to the German outbreak strain STEC O104
This joint report, produced by the ECDC and the European Food Safety Authority (EFSA), aims to give a short summary of reported Shiga toxin/verotoxin-producing Escherichia coli (STEC/VTEC) prevalence and incidence in humans, food and animals. A special reference is given to the strain STEC O104:H4, which has been isolated as the causative agent for the large outbreak of haemolytic uremic syndrome (HUS) reported in Germany in 2011. The publication focuses on cases reported in EU/EEA countries through the existing surveillance and monitoring systems of ECDC and EFSA and the comparison of characteristics of strains from earlier reported isolates/cases with the German outbreak strain.
Partial COVID-19 vaccination, vaccination following SARS-CoV-2 infection and heterologous vaccination schedule: summary of evidence
22 Jul 2021 - This document provides a review of evidence on three topics of interest (effectiveness of partial vaccination, immunogenicity and effectiveness of vaccination for previously infected individuals and safety and immunogenicity of heterologous schedules) to inform ongoing decision-making in relation to national vaccination policies and strategies in the European Union and European Economic Area (EU/EEA) countries.
COVID-19 in children and the role of school settings in transmission - second update
8 Jul 2021 - The aim of this document is to provide an update on the knowledge surrounding the role of children in the transmission of SARS-CoV-2 and the role of schools in the COVID-19 pandemic, focusing in particular on the experience in EU/EEA countries since the beginning of the pandemic. This document also addresses transmission to and from staff in school settings, school-related mitigation measures including risk communication, testing, contact tracing, and the effectiveness and impacts of school closures.
External quality assessment (EQA) schemes to support European surveillance of Legionnaires’ disease 2019−2020 - Western Balkans and Turkey
29 Jun 2021 - This is the first EQA exercise for laboratories participating in surveillance from the ELDSNet network that has been organised by ECDC since 2015 and the EQA format and arrangements have changed. The current EQA scheme uses an outbreak scenario with a package of clinical and environmental samples for the participating laboratories to process, depending on their technical capacity and protocols.